InMed Pharmaceuticals Growth Metrics (2021-2025) | INM

Growth Metrics Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) -15.83%-12.71%-4.88%10.31%-25.14%-9.84%-9.31%-16.19%-4.14%-44.27%-30.53%31.78%27.67%
Assets Growth (3y) -15.47%-24.02%-15.69%6.81%-2.88%
Assets (QoQ) 11.87%-20.11%-17.42%14.05%16.01%-12.94%-4.23%-22.61%39.74%-12.43%-11.50%-11.48%-18.76%9.15%67.89%-14.24%
Capital Expenditures (QoQ) -185.78%101.66%
Cash & Equivalents Growth (1y) -39.06%1.53%62.83%44.29%-27.94%-16.74%-20.86%-26.27%-17.14%-63.29%-38.16%68.54%68.37%
Cash & Equivalents Growth (3y) -28.61%-32.30%-7.29%21.49%0.18%
Cash & Equivalents (QoQ) -26.49%-47.71%4.72%51.38%22.48%-16.14%-7.20%-24.40%41.50%-20.29%-13.54%-15.04%-37.31%34.29%135.66%-15.13%
Cash from Investing Activities Growth (1y) -3,508.16%95.37%100.00%
Cash from Investing Activities (QoQ) 222.40%-101.16%-20,318.15%73.79%
Cash from Operations Growth (1y) 15.01%23.22%69.03%83.74%3.61%31.88%-16.76%-56.42%15.98%-35.39%14.21%-72.81%12.00%
Cash from Operations Growth (3y) 11.71%10.87%32.30%23.97%10.67%
Cash from Operations (QoQ) -33.15%-51.36%24.33%44.27%-20.29%38.94%60.28%-230.46%15.00%-4.66%46.79%-77.50%-36.97%33.68%-7.17%9.61%
EBITDA Margin Growth (1y) 92,945.00150,844.0079,940.0031,576.003,717.00-13769.0015,872.00-7017.00-1239.001,956.00-2643.00
EBITDA Margin Growth (3y) 95,422.00139,032.0093,170.00
EBITDA Margin (QoQ) -40619.0043,464.0064,700.0025,401.0017,281.00-27440.0016,335.00-2459.00-205.002,200.00-6554.003,319.002,990.00-2398.00
EBIT Growth (1y) -20.34%48.31%39.20%92.56%25.26%25.70%14.29%-319.30%35.09%-37.03%-15.90%10.53%-4.94%
EBIT Growth (3y) 16.42%19.26%15.48%34.65%20.15%
EBIT Margin Growth (1y) 93,521.00124,562.0081,838.0033,862.005,085.00-13755.0015,918.00-7012.00-1215.001,905.00-2535.00
EBIT Margin Growth (3y) 97,391.00112,712.0095,221.00
EBIT Margin (QoQ) -12326.0015,186.0064,349.0026,312.0018,714.00-27538.0016,374.00-2465.00-126.002,135.00-6556.003,332.002,994.00-2305.00
EBIT (QoQ) -44.12%17.35%-84.20%45.15%38.09%2.80%77.46%-450.94%38.46%-12.12%-10.30%14.71%-29.92%5.17%14.85%-0.04%
EBT Growth (1y) -17.90%51.01%42.56%95.72%27.59%29.55%13.70%-473.57%33.86%-74.20%-23.10%7.37%-2.92%
EBT Growth (3y) 17.35%15.60%15.18%38.98%21.01%
EBT Margin Growth (1y) 92,959.00151,431.0081,084.0032,742.004,617.00-13590.0014,861.00-11244.00-2119.001,340.00-2150.00
EBT Margin Growth (3y) 95,457.00139,181.0093,795.00
EBT Margin (QoQ) -40619.0043,676.0064,552.0025,351.0017,853.00-26672.0016,210.00-2774.00-354.001,779.00-9895.006,351.003,105.00-1710.00
EBT (QoQ) -44.12%18.85%-126.43%55.48%40.11%4.84%83.14%-653.68%41.73%-16.55%-12.06%13.09%-53.47%17.63%15.68%3.43%
Enterprise Value Growth (1y) -433.18%-233.49%-181.99%-982.29%-30.92%23.01%10.14%25.16%44.64%98.14%58.78%-63.71%-71.28%
Enterprise Value Growth (3y) -64.05%-26.39%-32.07%-133.98%-7.48%
Enterprise Value (QoQ) 604.87%2.62%-90.98%-610.82%-182.41%36.97%2.96%24.20%-66.07%26.43%19.18%43.93%94.43%-1,532.53%-221.00%41.33%
EPS (Basic) Growth (1y) 34.20%88.23%90.23%102.15%-275.37%-307.69%-496.67%-1,407.14%82.22%1.89%45.81%88.25%83.76%
EPS (Basic) Growth (3y) 23.99%22.20%31.89%67.93%52.32%
EPS (Basic) (QoQ) -25.28%20.57%-112.38%68.87%77.59%34.07%146.67%-5,542.86%75.66%3.50%-2.23%25.96%-34.32%46.70%77.84%-2.33%
EPS (Weighted Average and Diluted) Growth (1y) -2,562.39%82.22%1.89%45.81%88.25%83.76%
EPS (Weighted Average and Diluted) Growth (3y) 31.89%
EPS (Weighted Average and Diluted) (QoQ) -10,986.01%75.66%3.50%-2.23%25.96%-34.32%46.70%77.84%-2.33%
FCF Margin Growth (1y) 156,865.0075,640.0046,205.0042,850.00-473.00-5037.009,663.00-7605.003,342.00-5610.0093.00
FCF Margin Growth (3y) 159,733.0064,993.0055,960.00
FCF Margin (QoQ) 94,263.008,312.0012,560.0041,729.0013,038.00-21123.009,206.00-1594.008,475.00-6424.00-8062.009,353.00-477.00-721.00
Free Cash Flow Growth (1y) 22.33%18.26%69.05%82.96%3.61%31.88%-16.76%-49.21%15.98%-35.39%14.21%-72.81%12.00%
Free Cash Flow Growth (3y) 14.32%8.99%32.32%23.97%10.67%
Free Cash Flow (QoQ) -14.31%-61.25%24.38%44.27%-20.29%38.94%58.36%-215.22%15.00%-4.66%46.79%-77.50%-36.97%33.68%-7.17%9.61%
Gross Margin Growth (1y) -4026.001,944.0015,542.00-178.00607.00-3163.003,666.001,532.00-1076.00787.00-302.00
Gross Margin Growth (3y) -4496.00-431.0018,906.00
Gross Margin (QoQ) -1037.00-20158.0018,099.00-930.004,933.00-6560.002,378.00-145.001,164.00269.00244.00-2754.003,028.00-821.00
Gross Profit Growth (1y) 5.61%528.87%104.33%147.13%50.36%-70.32%2,222.82%42.19%-39.33%23.73%-18.29%
Gross Profit Growth (3y) -1.23%32.18%41.30%
Gross Profit (QoQ) 37.00%-296.63%126.71%46.77%715.74%-98.65%1,425.95%-10.70%61.02%5.87%-6.59%-61.89%228.34%-30.09%
Net Cash Flow Growth (1y) -60.23%164.03%65.65%-348.26%-168.51%-171.02%-4.64%-48.80%54.53%-17.07%165.16%721.59%-76.50%
Net Cash Flow Growth (3y) -28.54%18.95%30.73%184.23%-36.62%
Net Cash Flow (QoQ) -150.92%-32.42%105.18%1,039.30%-18.01%-171.04%62.59%-214.40%15.00%-4.66%46.80%3.93%-118.86%158.25%407.46%-127.28%
Net Income Growth (1y) -18.12%51.01%42.56%95.72%27.73%29.55%13.70%-473.57%33.86%-74.20%-23.10%7.37%-2.92%
Net Income Growth (3y) 17.35%15.60%15.18%38.98%21.06%
Net Income (QoQ) -44.12%18.85%-126.43%55.40%40.23%4.84%83.14%-653.68%41.73%-16.55%-12.06%13.09%-53.47%17.63%15.68%3.43%
Net Income towards Common Stockholders Growth (1y) -18.12%51.01%42.56%95.72%27.73%29.55%13.70%-473.57%33.86%-74.20%-23.10%7.37%-2.92%
Net Income towards Common Stockholders Growth (3y) 17.35%15.60%15.18%38.98%21.06%
Net Income towards Common Stockholders (QoQ) -44.12%18.85%-126.43%55.40%40.23%4.84%83.14%-653.68%41.73%-16.55%-12.06%13.09%-53.47%17.63%15.68%3.43%
Net Margin Growth (1y) 92,959.00151,431.0081,296.0032,742.004,617.00-13590.0014,861.00-11244.00-2119.001,340.00-2150.00
Net Margin Growth (3y) 95,457.00139,181.0094,007.00
Net Margin (QoQ) -40619.0043,464.0064,764.0025,351.0017,853.00-26672.0016,210.00-2774.00-354.001,779.00-9895.006,351.003,105.00-1710.00
Operating Income Growth (1y) 39.20%92.56%25.26%25.70%14.29%-319.30%35.09%-37.03%-15.90%10.53%-4.94%
Operating Income Growth (3y) 15.48%34.65%20.15%
Operating Income (QoQ) -84.20%45.15%38.09%2.80%77.46%-450.94%38.46%-12.12%-10.30%14.71%-29.92%5.17%14.85%-0.04%
Operating Margin Growth (1y) 93,521.00124,562.0081,838.0033,862.005,085.00-13755.0015,918.00-7012.00-1215.001,905.00-2535.00
Operating Margin Growth (3y) 97,391.00112,712.0095,221.00
Operating Margin (QoQ) -12326.0015,186.0064,349.0026,312.0018,714.00-27538.0016,374.00-2465.00-126.002,135.00-6556.003,332.002,994.00-2305.00
Profit After Tax Growth (1y) -18.12%29.29%42.52%95.70%27.73%29.65%13.77%-479.84%32.99%-74.20%-23.10%8.26%-1.58%
Profit After Tax Growth (3y) 16.99%4.66%15.18%38.84%21.06%
Profit After Tax (QoQ) 0.00%-16.96%-126.43%55.40%40.14%4.91%83.06%-649.67%41.73%-16.55%-13.89%13.36%-51.47%17.63%15.13%4.06%
Property, Plant & Equipment (Net) Growth (1y) 163.13%-35.81%-24.89%-20.00%-23.35%110.41%82.01%72.79%118.36%-16.89%-19.13%-20.62%-34.36%
Property, Plant & Equipment (Net) Growth (3y) 63.92%3.93%3.40%3.14%3.19%
Property, Plant & Equipment (Net) (QoQ) 259.63%-8.55%-9.83%-11.27%-12.27%7.01%-3.96%-14.98%140.81%-7.44%-8.82%7.44%-8.34%-9.94%-10.50%-11.15%
Return on Assets Growth (1y) 76.0084.0059.0055.00-6.00-5.00-35.00-51.00-5.004.00
Return on Assets Growth (3y) 66.0083.00
Return on Assets (QoQ) -8.0032.0010.0043.00-1.007.006.00-18.000.00-22.00-10.0028.009.00
Return on Capital Employed Growth (1y) 92.00105.0058.0055.00-9.00-7.00-41.00-64.002.0013.00
Return on Capital Employed Growth (3y) 85.00110.00
Return on Capital Employed (QoQ) -12.0054.0012.0039.001.006.009.00-25.002.00-28.00-13.0041.0013.00
Return on Equity Growth (1y) 121.00-364.00-264.0065.00-11.00477.00289.00-75.00-4.0012.00
Return on Equity Growth (3y) 107.00125.00
Return on Equity (QoQ) -4.0057.0018.0051.00-490.00157.00347.00-25.00-2.00-31.00-17.0046.0014.00
Return on Sales Growth (1y) 934.00554.0025.0010.00-48.00-61.002.00-34.00
Return on Sales (QoQ) 388.00469.0044.0032.008.00-59.0030.00-26.00-5.004.00-6.00
Revenue Growth (1y) 233.97%348.96%181.14%163.99%13.41%-44.48%40.23%-10.36%7.59%1.69%-11.43%
Revenue Growth (3y) 59.73%36.34%51.71%
Revenue (QoQ) 66.27%-37.68%46.45%120.09%123.52%-60.98%37.52%-5.45%9.42%-1.44%-12.09%13.48%3.42%-14.15%
Share-based Compensation Growth (1y) 4.98%-67.11%-74.19%-77.12%-78.41%-74.14%9.83%-3.77%14.98%26.80%-26.85%-31.38%-30.24%
Share-based Compensation Growth (3y) -36.13%-52.40%-40.81%-46.74%-44.26%
Share-based Compensation (QoQ) 93.25%-9.17%-9.33%-34.04%-39.46%-28.71%-19.61%-37.77%-27.50%202.81%-29.57%-25.65%-20.04%74.68%-33.93%-24.41%
Shareholder's Equity Growth (1y) -27.68%1.18%13.79%33.17%-187.01%-10.90%-10.36%-23.85%187.65%-51.60%-36.77%45.93%38.06%
Shareholder's Equity Growth (3y) -17.99%-24.15%-13.60%13.96%1.73%
Shareholder's Equity (QoQ) -6.93%-23.16%-16.61%21.25%30.22%-13.58%-2.40%-179.23%233.35%-13.06%-17.10%-8.81%-26.36%13.58%91.33%-13.72%
Total Debt (QoQ) -50.00%